Alyeska Investment Group, L.P. Sellas Life Sciences Group, Inc. Put Options Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SLS
# of Institutions
38Shares Held
7.08MCall Options Held
1.8MPut Options Held
49.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.71 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.41 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$865,5840.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$572,6740.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$507,8340.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24.3M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...